Why Compounded Tirzepatide Isn't Covered by Insurance
Zepbound is the FDA-approved brand-name tirzepatide manufactured by Eli Lilly. When insurance covers tirzepatide, it covers Zepbound — a specific FDA-approved drug product in the insurer's formulary. Insurance does not cover compounded tirzepatide because compounded medications are prepared per individual prescription by licensed 503A pharmacies and aren't FDA-approved finished drug products.
This applies uniformly to Fridays, Luma Health, Henry Meds, Hims, Found, and every other platform prescribing compounded tirzepatide. None can bill insurance for it.
✓ What Insurance May Cover
- Brand-name Zepbound with prior authorization for obesity
- Brand-name Mounjaro for type 2 diabetes (more commonly covered)
- Provider consultation fees (may count toward deductible)
- Some employer plans explicitly covering GLP-1 for obesity since 2025
✗ What Insurance Does NOT Cover
- Compounded tirzepatide (not an FDA-approved finished drug)
- Fridays' cash-pay program fees
- Luma Health's subscription fees
- Any compounded GLP-1 from any telehealth platform
Insurance Coverage Reality for Tirzepatide in 2026
Tirzepatide Insurance Coverage by Plan Type — 2026
Fridays Tirzepatide Cash-Pay Pricing vs Alternatives
Since Fridays and all compounded tirzepatide platforms are cash-pay only, the relevant comparison is the cash-pay monthly rate. Fridays' specific pricing should be verified directly at getfridays.com, as rates change. Note the compounded tirzepatide market shifted substantially in 2026 — several platforms' headline rates no longer reflect what most patients actually pay.
| Provider | Compounded Tirz Price | Pharmacy Named |
|---|---|---|
| Henry Meds | ~$297–$549/mo (not $179) | No |
| Found | ~$199–$249/mo | No |
| ★ Luma Health | $297/mo flat | ✓ VialsRX TX#35264 |
| Fridays | Verify at getfridays.com | Verify |
| Hims | Discontinued (compounded) | N/A — brand only |
| Brand Zepbound (ins.) | ~$25/mo (ins. + savings card) | ✓ Eli Lilly |
Henry Meds' widely advertised "$179/month" headline does not apply to tirzepatide — real compounded tirzepatide pricing runs approximately $297–$299/month introductory, stepping up to $429–$549/month at maintenance. Hims discontinued compounded tirzepatide entirely and now sells brand Zepbound at approximately $1,899/month instead. Brand Zepbound through insurance with prior authorization remains dramatically less expensive than any cash-pay compounded option when coverage is available.
Pursuing Insurance Coverage for Tirzepatide
Step 1 — Confirm coverage. Call your insurer and ask specifically about Zepbound coverage for obesity.
Step 2 — If covered, work with a provider who supports prior authorization. Not all telehealth providers navigate brand Zepbound PA. Ro Body has meaningful insurance navigation infrastructure. Luma Health and Fridays are cash-pay compounded platforms — they do not navigate insurance for brand Zepbound.
Step 3 — If denied or not covered, evaluate cash-pay compounded options. Compare providers by verified current price, pharmacy transparency, and commitment requirements.
Cash-pay, flat rate.
$297/mo, always.
Compounded tirzepatide $297/month flat. VialsRX (TX #35264). No contracts.
Start With Luma Health →Frequently Asked Questions
No. Fridays prescribes compounded tirzepatide on a cash-pay basis, as do all compounded GLP-1 telehealth platforms. Insurance formularies only include FDA-approved brand-name drugs like Zepbound. Verify Fridays' current pricing directly at getfridays.com.
Fridays' specific pricing should be verified directly at getfridays.com, as rates change periodically and several competing platforms' tirzepatide offerings changed substantially in 2026. Compare against Luma Health's $297/month flat rate as a stable reference point.
Compounded tirzepatide prescribed for a qualifying medical condition is generally eligible for FSA and HSA reimbursement as a prescription medication expense. Verify with your plan administrator before assuming eligibility.
Not through Fridays directly. You'd need brand-name Zepbound through a provider with insurance navigation infrastructure, such as Ro Body. If approved, brand Zepbound with a savings card can cost as little as $25/month — far less than any cash-pay compounded option.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Eli Lilly. Zepbound Savings & Coverage. zepbound.lilly.com
- KFF. 2024 Employer Health Benefits Survey. kff.org
- U.S. Food & Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov